Linc AB
Linc AB invests in product oriented companies in the Nordic Life Science industry.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Linc AB Information
Geographic Data
Address: Strandvägen 7A
City: Stockholm
State: stockholms län
Zip: 114 51
Country: SE
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Linc AB invests in product oriented companies in the Nordic Life Science industry. Linc AB mainly invest in and develop small and medium-sized product oriented life science companies in Medical Technology and Pharmaceuticals.
Contact Phone:
Contact Email:
Linc AB went public on 5/18/2021 on the STO
Listed Exchange:
STO
IPO Date:
5/18/2021
IPO Valuation:
$145M
Ticker Symbol:
LINC
IPO Price:
$8.811496854838799/share
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2022 | Initiator Pharma | Secondary Market | 2.1M |
| 11/2020 | OncoZenge | Venture Round | 1.2M |
| 12/2021 | Oncorena | Venture Round | 0 |
| 5/2022 | Cinclus Pharma | Venture Round | 0 |
| 3/2022 | FluoGuide | Post-IPO Equity | 0 |
| 7/2020 | Gesynta Pharma | Series C | 0 |
| 5/2022 | Cinclus Pharma | Venture Round | 0 |
| 3/2022 | FluoGuide | Post-IPO Equity | 0 |
| 12/2021 | Oncorena | Venture Round | 0 |
| 7/2020 | Gesynta Pharma | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
